| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |